Coredio offers a non-invasive SaaS application for real-time, device-driven cardiac monitoring, focusing on heart failure patients. The platform uses AI-assisted digital twin technology to derive intracardiac pressure, central blood pressure, and cardiac output from wearable sensors. This data assists cardiologists with progress tracking and medication titration, aiming to reduce unplanned hospital admissions and readmissions.
Funding
Funding not disclosed
Founders
Product
Problem
Managing heart failure patients post-discharge requires close monitoring of intra-cardiac pressure, cardiac output, and central blood pressure, which traditionally involves invasive procedures or frequent clinic visits. The lack of convenient and accurate methods for remote monitoring can lead to ineffective medication titration and increased unplanned hospital readmissions.
Solution
Coredio offers a non-invasive cardiac monitoring platform that utilizes AI-assisted digital twin technology to provide accurate measurements of intra-cardiac pressure, central blood pressure (cBP), and cardiac output (CO). The platform requires a one-time 20-minute calibration process using PPG, ECG, and portable ultrasound to personalize the digital twin for each patient, ensuring precision for up to three years. Cardiologists and heart failure nurses can then use the platform to monitor these key parameters on-demand, either within clinical settings or remotely, enabling timely medication adjustments and proactive intervention to avoid escalation of heart failure. Coredio aims to improve patient outcomes by providing the ability to track patient progress and optimize medication regimens, thereby reducing unplanned hospital admissions and readmissions.
Target Audience
The primary target audience includes cardiologists, heart failure nurses, and hospitals focused on improving outcomes for heart failure patients and reducing hospital readmissions.
Features
- Non-invasive measurement of intra-cardiac pressure using wearable sensors and AI-assisted digital twin technology (in validation)
- On-demand monitoring of cardiac output (CO) and central blood pressure (cBP) trends
- Arterial wall displacement monitoring to provide insights into cardiovascular risks and vessel health
- Pulse Transit Time (PTT) measurement as an indicator of arterial health and age
- One-time calibration process leveraging PPG, ECG, and portable ultrasound
- Deviation of less than 5 mmHg for central BP and less than 5% for CO
- Integration with PPG+ECG and cuff BP devices for seamless data collection